Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Epiva Biosciences

2014 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer of immunobiotic therapeutics designed to treat cancer, autoimmune and inflammatory diseases. The company's immunobiotic therapeutics is focused on the treatment of autoimmune diseases, inflammation and aberrant immune responses by modulating the host immune-bacteria interface, enabling patients to restore normo-biosis, a microbiome signature normally found in healthy people.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 790 Memorial Drive
  • Cambridge, MA 02139
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Epiva Biosciences’s full profile, request a free trial.

Epiva Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 12-Jul-2016 00.000 Completed Startup
2. Early Stage VC (Series A2) 28-Jan-2016 000.00 000.00 Cancelled Startup
1. Early Stage VC (Series A) 01-Jan-2015 $6.06M $6.06M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Epiva Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A2 00,000,000 00.000000 00 00 00 00 00 00.000
Series A 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
To view this company’s complete Cap Table, request access »

Epiva Biosciences Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Flagship Pioneering Venture Capital Minority 000 0000 000000 0

Epiva Biosciences Executive Team (6)

Name Title Board
Seat
Contact
Info
Brett Blackman Ph.D Senior Vice President, Translational Sciences and Chief Technology Officer
Neal Gordon Ph.D Head of Technical Operations
Amy Mendel JD Senior Vice President, Intellectual Property

3 Former Executives

You’re viewing 3 of 6 executives. Get the full list »

Epiva Biosciences Board Members (2)

Name Representing Role Since Contact
Info
David Perry Self Board Member 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »